Skip to main content
Premium Trial:

Request an Annual Quote

Rancho Biosciences Joins TranSMART Foundation


NEW YORK (GenomeWeb) – Rancho Biosciences said this week that it has become an affiliate member of the TranSMART Foundation, a non-profit organization that provides an open-source platform for scientists to share pre-competitive research data.

Recently, Rancho donated 11 manually curated datasets from the Gene Expression Omnibus for cancer, immunology, and asthma to the foundation to be used for testing and hackathons. The company also hosts a version of the TranSMART platform and allows researchers to test drive the system before deciding to adopt it internally.

This week the company said that it will work with the foundation to develop a new track named "Testathon" that will provide additional testing content and serve as a forum for reporting bugs to the development team ahead of the official platform launch.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.